{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T10:21:50Z","timestamp":1758190910716,"version":"3.44.0"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T00:00:00Z","timestamp":1758067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Polycystic ovary syndrome (PCOS) is a complex endocrine disorder characterized by hyperandrogenism, ovulatory dysfunction, and metabolic disturbances, including dyslipidaemia. Recent studies have suggested that intestinal surfeit locus protein 4 (SURF4) contributes to elevated serum PCSK9 levels and subsequent lipid accumulation, with evidence of sex-specific differences in its expression and regulatory effects. This study aimed to investigate the involvement of intestinal SURF4 in the pathogenesis of PCOS and its potential contribution to metabolic lipid disturbances, as well as to explore lipid-PCOS associations through Mendelian randomization (MR) analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This research established two rat models of PCOS: one by administering letrozole in combination with a high-fat diet (Model, <jats:italic>n<\/jats:italic>\u202f=\u202f5) and another by subcutaneous injection of DHEA (DHEA, <jats:italic>n<\/jats:italic>\u202f=\u202f5). Intestinal SURF4 expression levels were assessed using immunohistochemistry and quantitative polymerase chain reaction. Quantitative serum lipid profiles and androgen levels evaluated the metabolic and hormonal alterations associated with PCOS. Group differences were assessed using ANOVA with post-hoc tests. Mendelian randomization (MR) analyses were conducted to assess the causal relationship between genetic lipid traits and PCOS risk, using data from 10,074 PCOS cases and 103,164 controls.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The PCOS rat model exhibited significant upregulation of intestinal SURF4 accompanied by dyslipidaemia and elevated androgen levels. Elevated androgen levels may regulate intestinal SURF4 expression, contributing to disturbances in lipid metabolism. MR analyses indicated that PCOS leads to serum lipid abnormalities rather than vice versa.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>These findings suggest that intestinal SURF4 may serve as a potential intervention target for improving lipid metabolic disorders associated with PCOS.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fnut.2025.1644496","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T04:21:01Z","timestamp":1758082861000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Intestinal SURF4 in dyslipidaemia and female-specific metabolic disorders: insights from rats with polycystic ovary syndrome"],"prefix":"10.3389","volume":"12","author":[{"given":"Yating","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Si","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Ning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruyue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiu","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongting","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingling","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,9,17]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1210\/clinem\/dgad463","article-title":"Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"108","author":"Teede","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12916-022-02238-y","article-title":"Genomic correlation, shared loci, and causal relationship between obesity and polycystic ovary syndrome: a large-scale genome-wide cross-trait analysis","volume":"20","author":"Liu","year":"2022","journal-title":"BMC Med"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1123\/jpah.2022-0103","article-title":"Supervised aerobic exercise training and increased lifestyle physical activity to reduce cardiovascular disease risk for women with polycystic ovary syndrome: a randomized controlled feasibility trial","volume":"19","author":"Woodward","year":"2022","journal-title":"J Phys Act Health"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"e2238513","DOI":"10.1001\/jamanetworkopen.2022.38513","article-title":"Menstrual cycle regularity and length across the reproductive lifespan and risk of cardiovascular disease","volume":"5","author":"Wang","year":"2022","journal-title":"JAMA Netw Open"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1093\/humupd\/dmaa029","article-title":"Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis","volume":"26","author":"Wekker","year":"2020","journal-title":"Hum Reprod Update"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1229900","DOI":"10.3389\/fendo.2023.1229900","article-title":"The causal association between polycystic ovary syndrome and susceptibility and severity of COVID-19: a bidirectional Mendelian randomization study using genetic data","volume":"14","author":"Si","year":"2023","journal-title":"Front Endocrinol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s43032-022-00864-8","article-title":"The association between polycystic ovary syndrome and metabolic syndrome in adolescents: a systematic review and Meta-analysis","volume":"30","author":"Fu","year":"2023","journal-title":"Reprod Sci"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"814","DOI":"10.3109\/09513590.2010.508852","article-title":"Dyslipidemia in women with polycystic ovary syndrome: incidence, pattern and predictors","volume":"27","author":"Rocha","year":"2011","journal-title":"Gynecol Endocrinol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/s0002-9343(01)00948-2","article-title":"Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome","volume":"111","author":"Legro","year":"2001","journal-title":"Am J Med"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1093\/humrep\/det262","article-title":"Prevalence of polycystic ovary syndrome in women in China: a large community-based study","volume":"28","author":"Li","year":"2013","journal-title":"Hum Reprod"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"e1002953","DOI":"10.1371\/journal.pmed.1002953","article-title":"Progression of glucose intolerance and cardiometabolic risk factors over a decade in Chinese women with polycystic ovary syndrome: a case-control study","volume":"16","author":"Ng","year":"2019","journal-title":"PLoS Med"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s40001-023-01174-8","article-title":"Adiposity and lipid metabolism indicators mediate the adverse effect of glucose metabolism indicators on oogenesis and embryogenesis in PCOS women undergoing IVF\/ICSI cycles","volume":"28","author":"Jiang","year":"2023","journal-title":"Eur J Med Res"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1281794","DOI":"10.3389\/fendo.2023.1281794","article-title":"Effect of hyperlipidemia on the outcome of in vitro fertilization in non-obese patients with polycystic ovary syndrome","volume":"14","author":"Yang","year":"2023","journal-title":"Front Endocrinol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1080\/09513590.2018.1540570","article-title":"Comparison of myo-inositol and metformin on glycemic control, lipid profiles, and gene expression related to insulin and lipid metabolism in women with polycystic ovary syndrome: a randomized controlled clinical trial","volume":"35","author":"Shokrpour","year":"2019","journal-title":"Gynecol Endocrinol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"2938","DOI":"10.3390\/nu13092938","article-title":"Effect of nutritional supplementation on oxidative stress and hormonal and lipid profiles in PCOS-affected females","volume":"13","author":"Dubey","year":"2021","journal-title":"Nutrients"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1186\/s12967-020-02519-1","article-title":"Impact of different omega-3 fatty acid sources on lipid, hormonal, blood glucose, weight gain and histopathological damages profile in PCOS rat model","volume":"18","author":"Komal","year":"2020","journal-title":"J Transl Med"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1002\/ddr.22027","article-title":"PDE4 inhibitor Roflumilast modulates inflammation and lipid accumulation in PCOS mice to improve ovarian function and reduce DHEA-induced granulosa cell apoptosis in vitro","volume":"84","author":"Ji","year":"2023","journal-title":"Drug Dev Res"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1080\/09513590.2017.1418853","article-title":"Evaluation of prolonged use of statins on the clinical and biochemical abnormalities and ovulation dysfunction in single young women with polycystic ovary syndrome","volume":"34","author":"Seyam","year":"2018","journal-title":"Gynecol Endocrinol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.tem.2007.07.004","article-title":"Pathophysiology and types of dyslipidemia in PCOS","volume":"18","author":"Diamanti-Kandarakis","year":"2007","journal-title":"Trends Endocrinol Metab"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"5697","DOI":"10.19082\/5697","article-title":"Risk factors associated with metabolic syndrome and cardiovascular disease among women with polycystic ovary syndrome in Tabuk, Saudi Arabia","volume":"9","author":"Shaman","year":"2017","journal-title":"Electron Physician"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"892125","DOI":"10.3389\/fendo.2022.892125","article-title":"The lipid profiles in different characteristics of women with PCOS and the interaction between dyslipidemia and metabolic disorder states: a retrospective study in Chinese population","volume":"13","author":"Guo","year":"2022","journal-title":"Front Endocrinol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1055\/s-0043-121264","article-title":"The PCOS patients differ in lipid profile according to their phenotypes","volume":"126","author":"Spa\u0142kowska","year":"2018","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1515\/hmbci-2018-0002","article-title":"The impact of mild hypercholesterolemia on glycemic and hormonal profiles, menstrual characteristics and the ovarian morphology of women with polycystic ovarian syndrome","volume":"34","author":"Pergialiotis","year":"2018","journal-title":"Horm Mol Biol Clin Investig"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.fertnstert.2010.12.027","article-title":"Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis","volume":"95","author":"Wild","year":"2011","journal-title":"Fertil Steril"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.fertnstert.2022.04.027","article-title":"Liraglutide 3 mg on weight, body composition, and hormonal and metabolic parameters in women with obesity and polycystic ovary syndrome: a randomized placebo-controlled-phase 3 study","volume":"118","author":"Elkind-Hirsch","year":"2022","journal-title":"Fertil Steril"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"E689","DOI":"10.1152\/ajpendo.00213.2021","article-title":"Saturated fat ingestion stimulates proatherogenic inflammation in polycystic ovary syndrome","volume":"321","author":"Gonz\u00e1lez","year":"2021","journal-title":"Am J Phys Endocrinol Metab"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"e0227450","DOI":"10.1371\/journal.pone.0227450","article-title":"Murine Surf4 is essential for early embryonic development","volume":"15","author":"Emmer","year":"2020","journal-title":"PLoS One"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.cmet.2020.10.020","article-title":"Receptor-mediated ER export of lipoproteins controls lipid homeostasis in mice and humans","volume":"33","author":"Wang","year":"2021","journal-title":"Cell Metab"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"0435","DOI":"10.34133\/research.0435","article-title":"Hepatic Surf4 deficiency impairs serum amyloid A1 secretion and attenuates liver fibrosis in mice","volume":"7","author":"Wang","year":"2024","journal-title":"Research"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/s41575-019-0250-7","article-title":"Regulation of intestinal lipid metabolism: current concepts and relevance to disease","volume":"17","author":"Ko","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"101847","DOI":"10.1016\/j.molmet.2023.101847","article-title":"Intestinal SURF4 is essential for apolipoprotein transport and lipoprotein secretion","volume":"79","author":"Guo","year":"2024","journal-title":"Mol Metab"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1161\/ATVBAHA.123.318980","article-title":"Surf4 deficiency reduces intestinal lipid absorption and secretion and decreases metabolism in mice","volume":"43","author":"Tao","year":"2023","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"3130","DOI":"10.3390\/nu15143130","article-title":"The association between circulating lipids and female infertility risk: a univariable and multivariable Mendelian randomization analysis","volume":"15","author":"Zhu","year":"2023","journal-title":"Nutrients"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"e1007813","DOI":"10.1371\/journal.pgen.1007813","article-title":"Large-scale genome-wide meta-analysis of polycystic ovary syndrome suggests shared genetic architecture for different diagnosis criteria","volume":"14","author":"Day","year":"2018","journal-title":"PLoS Genet"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"e1003062","DOI":"10.1371\/journal.pmed.1003062","article-title":"Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: a multivariable Mendelian randomisation analysis","volume":"17","author":"Richardson","year":"2020","journal-title":"PLoS Med"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1002\/jrsm.1346","article-title":"Meta-analysis and Mendelian randomization: a review","volume":"10","author":"Bowden","year":"2019","journal-title":"Res Synth Methods"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/s42003-022-03417-6","article-title":"Cargo receptor Surf4 regulates endoplasmic reticulum export of proinsulin in pancreatic \u03b2-cells","volume":"5","author":"Saegusa","year":"2022","journal-title":"Commun Biol"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1093\/humrep\/des191","article-title":"Apolipoprotein A-I and B levels, dyslipidemia and metabolic syndrome in south-west Chinese women with PCOS","volume":"27","author":"Zhang","year":"2012","journal-title":"Hum Reprod"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1038\/s42003-024-06857-4","article-title":"CTBP1 links metabolic syndrome to polycystic ovary syndrome through interruption of aromatase and SREBP1","volume":"7","author":"Kong","year":"2024","journal-title":"Commun Biol"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"153654","DOI":"10.1016\/j.phymed.2021.153654","article-title":"Berberine improves ovulation and endometrial receptivity in polycystic ovary syndrome","volume":"91","author":"Wang","year":"2021","journal-title":"Phytomedicine"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.1001\/jama.2017.7217","article-title":"Effect of acupuncture and clomiphene in Chinese women with polycystic ovary syndrome: a randomized clinical trial","volume":"317","author":"Wu","year":"2017","journal-title":"JAMA"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"717","DOI":"10.12114\/j.issn.1007-9572.2023.0305","article-title":"Analysis of factors influencing hyperlipidemia in female polycystic ovary syndrome patients with normal body mass index","volume":"27","author":"Liu","year":"2023","journal-title":"Chin Gen Pract"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"e0269191","DOI":"10.1371\/journal.pone.0269191","article-title":"Causality of anthropometric markers associated with polycystic ovarian syndrome: findings of a Mendelian randomization study","volume":"17","author":"De Silva","year":"2022","journal-title":"PLoS One"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1093\/humrep\/dead053","article-title":"Childhood, adolescent, and adulthood adiposity are associated with risk of PCOS: a Mendelian randomization study with meta-analysis","volume":"38","author":"Dobbie","year":"2023","journal-title":"Hum Reprod"}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2025.1644496\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T04:21:23Z","timestamp":1758082883000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2025.1644496\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,17]]},"references-count":44,"alternative-id":["10.3389\/fnut.2025.1644496"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2025.1644496","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,17]]},"article-number":"1644496"}}